Early results of laser «Greenlight» 120W (experience of 150 operations) in the treatment of patients with benign prostatic hyperplasia prostate


С. В. Головко


The purpose of the clinical evaluation was the application of a transurethral prostate PVP (RV) using a laser power of 120 W in men with lower urinary tract symptoms (LUTS) due to benign prostatic hyperplasia (BPH). The study found that PVP RV (FVPZH) is an effective treatment of LUTS due to BPH. There has been an improvement in performance according to IPSS, QoL immediately after surgery. Our study confirmed a significant improvement in urodynamic results after FVPZH, a small number of complications. Furthermore, it can be safely used in high risk patients (i.e. patients receiving anticoagulant or in patients with severe pathology kardiolegochnoy). Clinical results FVPZH similar to the corresponding results after the application of a transurethral resection of the prostate, while reducing the risk of the operation, even in high risk patients. These clinical ben efits are confirmed by the relevant urodynamic parameters. But the potential benefits of using 120 watts «green laser» is still not proven large randomized trials.


How to Cite
Головко, С. В. (2015). Early results of laser «Greenlight» 120W (experience of 150 operations) in the treatment of patients with benign prostatic hyperplasia prostate. Health of Man, (4(55), 31–33. https://doi.org/10.30841/2307-5090.4(55).2015.104561
For practicing physicians
Author Biography

С. В. Головко, Клиника урологии Главного военно медицинского клинического центра

S.V. Golovko


Bachmann A, Ruszat R, Wyler S, et al. Photoselective vaporization of the prostate: the Basel experience after 108 procedures. Eur Urol 2005; 47: 798–804.

Barber NJ, Zhu G, Donohue JF, et al. Use of expired breath ethanol measure ments in evaluation of irrigant absorbtion during high power potassium titanyl phosphate laser vaporization of prostate. Urology 2006; 67: 80–3.

Cornu J N, Ahyai S, Bachmann A, de la Rosette J, Gilling P, Gratzke C et al. A systematic review and meta analysis of functional outcomes and complications following transurethral procedures for lower urinary tract symptoms resulting from benign prostatic obstruction: an update. Eur Urol 2014.

Kaplan SA. Expending the role of photoselective vaporization of the prostate. Rev Urol 2006; 8 (Suppl 3): S 3–8.

Kollmorgen TA, Malek RS, Barrett DM. Laser prostatectomy: two and half years’ experience with aggressive multifocal therapy. Urology 1996; 48: 217–22.

Lee R, Gonzalez RR, Te AE. The evolution of photoselective vaporization prostatectomy (PVP): advancing the surgical treatment of benign prostatic hyperplasia. World J Urol 2006; 24: 405–9.

Malek R, Kuntzman R, Barrett D. Photoselective potassium titanyl phophate laser vaporization of the benign obstructive prostate: observations on long term out comes. J Urol 2005; 174: 1344–1348.

Sandhu J, Ng C, Vanderbrink, et al. High power potassium titanyl phosphate photoselective laser vaporization of prostate for treatment of benign prostatic hyperplasia in men with large prostates. Urology 2004; 64: 1155–1159.

Sarica K, Alkan E, Luleci H, Tasci A. Photoselective vaporization of the enlarged prostate with KTP laser: long term results in 240 patients. J Endourol 2005; 19: 1199–1202.

Rajbabu K, Chandrasekara SK, Barber NJ, Walsh K, Muir GH. Photoselective vaporization of the prostate with the potassium titanyl phosphate laser in men with prostates of >100 mL. BJU Int 2007; 100: 593–8.

Reich O, Bachmann A, Schneede P, et al. Experimental comparison of high power (80 W) potassium titanyl phosphate laser vaporization and transurethral resection of the prostate. J Urol 2004; 171: 2502–4.

Ruszat R, Wyler S, Forster T, et al. Safety and effectiveness of photoselective vaporization of the prostate (PVP) in patients on ongoing oral anticoagulation. Eur Urol 2007; 51: 1031–1038; discussions 1038–1041.

Te A, Malloy TR, Stein BS, et al. Photoselective vaporization of the prostate for the treatment of benign prostatic hyperplasia: 12 month results from the first United states multicenter prospective study. J Urol 2004; 172: 1404–1408.

Woo H, Reich O, Bachmann A, et al. Outcomes of GreenLight HPS 120 W laser therapy in specific patient populations: those in retention, on anticoagu lants, and with lager prostates (≥80 ml). Eur Urol Suppl 2008; 7: 378–383.